These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 33485109)

  • 1. Institution of prothrombin complex concentrate protocols is associated with a reduction in plasma administration at a Tertiary Care Hospital.
    Carabini LM; Budd AN; Bochey P; Shayan S; Ramsey G; McCarthy RJ
    J Clin Anesth; 2021 Jun; 70():110164. PubMed ID: 33485109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraoperative Administration of 4-Factor Prothrombin Complex Concentrate Reduces Blood Requirements in Cardiac Transplantation.
    Sun GH; Patel V; Moreno-Duarte I; Zahedi F; Ursprung E; Couper G; Chen FY; Welsby IJ; Comenzo R; Kao G; Cobey FC
    J Cardiothorac Vasc Anesth; 2018 Feb; 32(1):161-167. PubMed ID: 29198634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the safety and efficacy between 3-factor and 4-factor prothrombin complex concentrates for the reversal of warfarin.
    Kuroski JE; Young S
    Am J Emerg Med; 2017 Jun; 35(6):871-874. PubMed ID: 28161220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Four-factor prothrombin complex concentrate for life-threatening bleeds or emergent surgery: A retrospective evaluation.
    Sin JH; Berger K; Lesch CA
    J Crit Care; 2016 Dec; 36():166-172. PubMed ID: 27546767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of four-factor prothrombin complex concentrate fixed, weight-based dosing for reversal of warfarin anticoagulation.
    Endres K; St Bernard R; Chin-Yee I; Hsia C; Lazo-Langner A
    Hematology; 2020 Dec; 25(1):489-493. PubMed ID: 33317427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost comparison of andexanet versus prothrombin complex concentrates for direct factor Xa inhibitor reversal after hemorrhage.
    Frontera JA; Bhatt P; Lalchan R; Yaghi S; Ahuja T; Papadopoulos J; Joset D
    J Thromb Thrombolysis; 2020 Jan; 49(1):121-131. PubMed ID: 31664662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prothrombin Complex Concentrates for Warfarin Reversal Before Heart Transplantation.
    Wanek MR; Hodges K; Persaud RA; Lam SW; Soltesz EG; Tong MZ; Moazami N
    Ann Thorac Surg; 2019 May; 107(5):1409-1415. PubMed ID: 30476474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new kid on the block: Outcomes with Kcentra 1 year after approval.
    Berndtson AE; Huang WT; Box K; Kobayashi L; Godat LN; Smith AM; Weingarten D; Coimbra R
    J Trauma Acute Care Surg; 2015 Dec; 79(6):1004-8. PubMed ID: 26488322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Tertiary Academic Medical Center Blood Bank's Experience With Four-Factor Prothrombin Complex Concentrate.
    Shmookler AD; Nichols TL; Perrotta PL
    Am J Clin Pathol; 2021 Jul; 156(2):246-252. PubMed ID: 33609094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjusted versus actual body weight dosing of 4-factor prothrombin complex concentrate in obese patients with warfarin-associated major bleeding.
    Smetana KS; Ziemba R; May CC; Erdman MJ; Van Matre ET; Jones GM
    J Thromb Thrombolysis; 2019 Apr; 47(3):369-374. PubMed ID: 30460443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On-label compared to off-label four-factor prothrombin complex concentrate use: a retrospective, observational study.
    Cho BC; Jung YH; DeMario VM; Lau E; Podlasek SJ; Grant MC; Gehrie EA; Frank SM
    Transfusion; 2019 Aug; 59(8):2678-2684. PubMed ID: 31121073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of thromboembolic events following administration of four-factor prothrombin complex concentrate (4F-PCC) for oral anticoagulation reversal.
    Makhoul T; Kelly G; Kersten B; Nadler M; Zammit CG; Jones CMC; Scott R; Acquisto NM
    Thromb Res; 2020 Oct; 194():158-164. PubMed ID: 32788109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacist Presence Decreases Time to Prothrombin Complex Concentrate in Emergency Department Patients with Life-Threatening Bleeding and Urgent Procedures.
    Masic D; Hidalgo DC; Kuhrau S; Chaney W; Rech MA
    J Emerg Med; 2019 Nov; 57(5):620-628. PubMed ID: 31447188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety, efficacy, and cost of four-factor prothrombin complex concentrate (4F-PCC) in patients with factor Xa inhibitor-related bleeding: a retrospective study.
    Smith MN; Deloney L; Carter C; Weant KA; Eriksson EA
    J Thromb Thrombolysis; 2019 Aug; 48(2):250-255. PubMed ID: 30941571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Four-factor prothrombin complex concentrate use for on-label versus off-label indications: a retrospective cohort study.
    Adkins BD; Shaim H; Abid A; Gonzalez A; DeAnda A; Yates SG
    J Thromb Thrombolysis; 2023 Jan; 55(1):74-82. PubMed ID: 35699871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Fresh-Frozen Plasma, Four-Factor Prothrombin Complex Concentrates, and Recombinant Factor VIIa to Facilitate Procedures in Critically Ill Patients with Coagulopathy from Liver Disease: A Retrospective Cohort Study.
    Kwon JO; MacLaren R
    Pharmacotherapy; 2016 Oct; 36(10):1047-1054. PubMed ID: 27547916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergent reversal of vitamin K antagonists: addressing all the factors.
    Martin DT; Barton CA; Dodgion C; Schreiber M
    Am J Surg; 2016 May; 211(5):919-25. PubMed ID: 27046797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prothrombin Complex Concentrate Reduces Blood Product Utilization in Heart Transplantation.
    Enter DH; Zaki AL; Marsh M; Cool N; Kruse J; Li Z; Andrei AC; Iddriss A; McCarthy PM; Malaisrie SC; Anderson A; Rich JD; Pham DT
    Pharmacotherapy; 2017 Oct; 37(10):1215-1220. PubMed ID: 28833357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Four factor prothrombin complex concentrate for warfarin reversal in patients with left ventricular assist devices.
    Rimsans J; Levesque A; Lyons E; Sylvester K; Givertz MM; Mehra MR; Stewart GC; Connors JM
    J Thromb Thrombolysis; 2018 Aug; 46(2):180-185. PubMed ID: 29785470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of a Four-factor Prothrombin Complex Concentrate Versus Plasma for Vitamin K Antagonist Reversal: An Integrated Analysis of Two Phase IIIb Clinical Trials.
    Milling TJ; Refaai MA; Sarode R; Lewis B; Mangione A; Durn BL; Harman A; Lee ML; Goldstein JN
    Acad Emerg Med; 2016 Apr; 23(4):466-75. PubMed ID: 26822172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.